PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsBeclomethasone
Beclovent, Trimbow(beclomethasone dipropionate)
Beconase, CHF 5993 Chiesi Farmaceutici S.p.A, Qnasl, Qvar, Riarify, Trimbow, Trydonis, Vancenase (beclomethasone dipropionate) is a small molecule pharmaceutical. Beclomethasone dipropionate was first approved as Beclovent on 1982-01-01. It is used to treat allergic rhinitis perennial and inflammation in the USA. It has been approved in Europe to treat chronic obstructive pulmonary disease. It is known to target adhesion G protein-coupled receptor G3.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
immune system diseasesD007154
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Qnasl, Qvar (discontinued: Beclovent, Beconase, Qvar, Vancenase, Vanceril)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Beclomethasone dipropionate
Tradename
Company
Number
Date
Products
QVAR REDIHALERNorton WaterfordN-207921 RX2017-08-03
2 products, RLD
QNASLTevaN-202813 RX2012-03-23
2 products, RLD, RS
Show 7 discontinued
Beclomethasone dipropionate monohydrate
Tradename
Company
Number
Date
Products
BECONASE AQGSKN-019389 DISCN1987-07-27
1 products, RLD
VANCENASE AQMerck & CoN-019589 DISCN1987-12-23
1 products
VANCENASE AQMerck & CoN-020469 DISCN1996-06-26
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
5 in 1 clipper spryOTC monograph not final2020-10-16
beconaseNew Drug Application2010-09-08
beconase aqNew Drug Application2009-10-27
qnaslNew Drug Application2022-09-27
qvarNew Drug Application2018-08-31
qvar redihalerNew Drug Application2025-08-20
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
inflammationMP_0001845D007249—
allergic rhinitis perennialEFO_1001417D012221J30.89
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Beclomethasone Dipropionate, Qvar Redihaler, Norton Waterford
115836432041-08-19DP
115596372039-07-21DP
107924472039-01-25DP
113958882038-01-26DP
117939532038-01-26DP
118652472038-01-26DP
89314762031-07-17DP
81327122028-09-07DP
Beclomethasone Dipropionate, Qvar 40, Teva Branded Pharm
105618082032-01-01DP
94632892031-05-18DP
98085872031-05-18DP
100225092031-05-18DP
100225102031-05-18DP
100861562031-05-18DP
106955122031-05-18DP
113958892031-05-18DP
Beclomethasone Dipropionate, Qnasl, Teva Branded Pharm
101888112031-10-21DP
77800382027-01-24DP
ATC Codes
A: Alimentary tract and metabolism drugs
— A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents
— A07E: Intestinal antiinflammatory agents
— A07EA: Corticosteroids acting locally
— A07EA07: Beclometasone
D: Dermatologicals
— D07: Corticosteroids, dermatological preparations
— D07A: Corticosteroid dermatological preparations, plain
— D07AC: Corticosteroids, potent (group iii)
— D07AC15: Beclometasone
— D07C: Corticosteroids, combinations with antibiotics
— D07CC: Corticosteroids, potent, combinations with antibiotics
— D07CC04: Beclometasone and antibiotics
R: Respiratory system drugs
— R01: Nasal preparations
— R01A: Decongestants and other nasal preparations for topical use
— R01AD: Corticosteroid nasal preparations for topical use
— R01AD01: Beclometasone
— R03: Drugs for obstructive airway diseases
— R03A: Adrenergics, inhalants
— R03AK: Adrenergics inhalants in combination with corticosteroids or other drugs, excl. anticholinergics
— R03AK08: Formoterol and beclometasone
— R03AK13: Salbutamol and beclometasone
— R03AL: Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
— R03AL09: Formoterol, glycopyrronium bromide and beclometasone
— R03B: Other drugs for obstructive airway diseases, inhalants in atc
— R03BA: Glucocorticoid inhalants for obstructive airway disease
— R03BA01: Beclometasone
HCPCS
No data
Clinical
Clinical Trials
251 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AsthmaD001249EFO_0000270J45517213853
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.964134531
Obstructive lung diseasesD008173——31112421
Lung diseasesD008171EFO_0003818J98.4—1112216
EmphysemaD004646EFO_0000464J43———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Disease progressionD018450————1——1
BronchiectasisD001987—J47——1——1
SinusitisD012852EFO_0007486J32——1——1
RhinosinusitisD000096825————1——1
CroupD003440EFO_0007227J05.0——1——1
LaryngitisD007827————1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
FibrosisD005355———1———1
Idiopathic pulmonary fibrosisD054990—J84.112—1———1
Pulmonary fibrosisD011658—J84.10—1———1
Tissue adhesionsD000267———1———1
Covid-19D000086382—U07.1—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Respiratory aspirationD053120EFO_1001839—1————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBeclomethasone dipropionate
INNbeclometasone
Description
Beclomethasone dipropionate is a steroid ester comprising beclomethasone having propionyl groups at the 17- and 21-positions. It has a role as an anti-inflammatory drug, an anti-asthmatic drug, a prodrug and an anti-arrhythmia drug. It is a steroid ester, an enone, a 20-oxo steroid, an 11beta-hydroxy steroid, a propanoate ester, a corticosteroid, a glucocorticoid, a 3-oxo-Delta(1),Delta(4)-steroid and a chlorinated steroid. It is functionally related to a beclomethasone.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C
Identifiers
PDB—
CAS-ID5534-09-8
RxCUI—
ChEMBL IDCHEMBL1200500
ChEBI ID3002
PubChem CID21700
DrugBankDB00394
UNII IDKGZ1SLC28Z (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
ADGRG3
ADGRG3
Organism
Homo sapiens
Gene name
ADGRG3
Gene synonyms
GPR97, PGR26
NCBI Gene ID
222487
Protein name
adhesion G protein-coupled receptor G3
Protein synonyms
G protein-coupled receptor 97, G-protein coupled receptor 97, G-protein coupled receptor PGR26, probable G-protein coupled receptor 97
Uniprot ID
Q8IZF1
Mouse ortholog
Adgrg3 (54672)
adhesion G protein-coupled receptor G3 (Q8R0T6)
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Qvar – Teva
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Beclomethasone dipropionate
+
Beclomethasone
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
8,783 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use